{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:22:38Z","timestamp":1783466558967,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009526","name":"Amrita Vishwa Vidyapeetham","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009526","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51900-5","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:19:17Z","timestamp":1778159957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials"],"prefix":"10.1038","volume":"16","author":[{"given":"Ayana R.","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Divya","family":"Dharshini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswathy R.","family":"Devan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok R.","family":"Unni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Sithara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagyalakshmi","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya Jayaprakash","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Sah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pavithran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sabitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Sudheesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lekshmi R.","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"23","key":"51900_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315054","volume":"23","author":"A Periferakis","year":"2022","unstructured":"Periferakis, A. et al. Kaempferol: Antimicrobial properties, sources, clinical, and traditional applications. Int. J. Mol. Sci. 23(23), 15054 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"51900_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s13205-013-0117-5","volume":"3","author":"P Batra","year":"2013","unstructured":"Batra, P. & Sharma, A. K. Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech. 3(6), 439\u2013459. https:\/\/doi.org\/10.1007\/s13205-013-0117-5 (2013).","journal-title":"3 Biotech."},{"key":"51900_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2174\/138955711795305335","volume":"11","author":"JM Calderon-Montano","year":"2011","unstructured":"Calderon-Montano, J. M., Burgos-Moron, E., Perez-Guerrero, C. & Lopez-Lazaro, M. A review on the dietary flavonoid kaempferol. Mini-Rev. Med. Chem. 11, 298\u2013344. https:\/\/doi.org\/10.2174\/138955711795305335 (2011).","journal-title":"Mini-Rev. Med. Chem."},{"issue":"7","key":"51900_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/bdd.677","volume":"30","author":"A Barve","year":"2009","unstructured":"Barve, A. et al. Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats. Biopharm. Drug Dispos. 30(7), 356\u2013365. https:\/\/doi.org\/10.1002\/bdd.677 (2009).","journal-title":"Biopharm. Drug Dispos."},{"key":"51900_CR5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1208\/s12248-016-9951-9","volume":"18","author":"L Zheng","year":"2016","unstructured":"Zheng, L. et al. In vivo exposure of kaempferol is driven by phase II metabolic enzymes and efflux transporters. AAPS. J. 18, 1289\u20131299. https:\/\/doi.org\/10.1208\/s12248-016-9951-9 (2016).","journal-title":"AAPS. J."},{"key":"51900_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2020.111825","volume":"205","author":"S Das","year":"2020","unstructured":"Das, S. et al. Exploring the interaction of bioactive kaempferol with serum albumin, lysozyme and hemoglobin: A biophysical investigation using multi-spectroscopic, docking and molecular dynamics simulation studies. J. Photochem. Photobiol. B 205, 111825 (2020).","journal-title":"J. Photochem. Photobiol. B"},{"key":"51900_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.saa.2012.07.043","volume":"96","author":"I Matei","year":"2012","unstructured":"Matei, I., Ionescu, S. & Hillebrand, M. Kaempferol\u2013human serum albumin interaction: Characterization of the induced chirality upon binding by experimental circular dichroism and TDDFT calculations. Spectrochim. Acta A Mol. Biomol. Spectrosc. 96, 709\u2013715 (2012).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"8","key":"51900_CR8","doi-asserted-by":"publisher","first-page":"2073S","DOI":"10.1093\/jn\/130.8.2073S","volume":"130","author":"A Scalbert","year":"2000","unstructured":"Scalbert, A. & Williamson, G. Dietary intake and bioavailability of polyphenols. J. Nutr. 130(8), 2073S-2085S (2000).","journal-title":"J. Nutr."},{"issue":"3","key":"51900_CR9","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1318-y","volume":"20","author":"M Colombo","year":"2019","unstructured":"Colombo, M. et al. Solid dispersion of kaempferol: Formulation development, characterization, and oral bioavailability assessment. AAPS PharmSciTech 20(3), 106. https:\/\/doi.org\/10.1208\/s12249-019-1318-y (2019).","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"51900_CR10","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1007\/s13346-023-01357-0","volume":"13","author":"W He","year":"2023","unstructured":"He, W. et al. Preparation, characterization, and evaluation of the antitumor effect of kaempferol nanosuspensions. Drug Deliv. Transl. Res. 13(11), 2885\u20132902 (2023).","journal-title":"Drug Deliv. Transl. Res."},{"issue":"3","key":"51900_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/abbs\/gmv133","volume":"48","author":"Y Qin","year":"2016","unstructured":"Qin, Y., Cui, W., Yang, X. & Tong, B. Kaempferol inhibits the growth and metastasis of cholangiocarcinoma in vitro and in vivo. Acta Biochim. Biophys. Sin. 48(3), 238\u2013245. https:\/\/doi.org\/10.1093\/abbs\/gmv133 (2016).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"51900_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jpba.2015.05.017","volume":"114","author":"K Zhang","year":"2015","unstructured":"Zhang, K. et al. Preparation and evaluation of kaempferol\u2013phospholipid complex for pharmacokinetics and bioavailability in SD rats. J. Pharm. Biomed. Anal. 114, 168\u2013175 (2015).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"51900_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125261","author":"SK Sah","year":"2025","unstructured":"Sah, S. K. et al. Ternary complex of Kaempferol-Hydroxypropyl-\u03b2-Cyclodextrin-liposomes against hepatocellular carcinoma: Preparation, validation, pharmacokinetics and efficacy studies. Int. J. Pharm. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125261 (2025).","journal-title":"Int. J. Pharm."},{"issue":"7","key":"51900_CR14","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/cas.15377","volume":"113","author":"G Milano","year":"2022","unstructured":"Milano, G., Innocenti, F. & Minami, H. Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs. Cancer Sci. 113(7), 2224\u20132231. https:\/\/doi.org\/10.1111\/cas.15377 (2022).","journal-title":"Cancer Sci."},{"issue":"11","key":"51900_CR15","volume":"6","author":"E Mora","year":"2016","unstructured":"Mora, E., Smith, E. M., Donohoe, C. & Hertz, D. L. Vincristine-induced peripheral neuropathy in pediatric cancer patients. Am. J. Cancer Res. 6(11), 2416 (2016).","journal-title":"Am. J. Cancer Res."},{"issue":"9","key":"51900_CR16","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1200\/JCO.1994.12.9.1754","volume":"12","author":"EK Rowinsky","year":"1994","unstructured":"Rowinsky, E. K. et al. Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors. J. Clin. Oncol. 12(9), 1754\u20131763. https:\/\/doi.org\/10.1200\/JCO.1994.12.9.1754 (1994).","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"51900_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00280-012-2042-4","volume":"71","author":"JA Silverman","year":"2013","unstructured":"Silverman, J. A. & Deitcher, S. R. Marqibo\u00ae(vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemother. Pharmacol. 71(3), 555\u2013564. https:\/\/doi.org\/10.1007\/s00280-012-2042-4 (2013).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"51900_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/10717541003777233","volume":"17","author":"SJ Torne","year":"2010","unstructured":"Torne, S. J., Ansari, K. A., Vavia, P. R., Trotta, F. & Cavalli, R. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges. Drug Deliv. 17(6), 419\u2013425. https:\/\/doi.org\/10.3109\/10717541003777233 (2010).","journal-title":"Drug Deliv."},{"issue":"3","key":"51900_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jconrel.2012.09.006","volume":"163","author":"\u0160 Koudelka","year":"2012","unstructured":"Koudelka, \u0160 & Tur\u00e1nek, J. Liposomal paclitaxel formulations. J. Control. Release 163(3), 322\u2013334. https:\/\/doi.org\/10.1016\/j.jconrel.2012.09.006 (2012).","journal-title":"J. Control. Release"},{"issue":"1","key":"51900_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-11860-3","volume":"24","author":"R Li","year":"2024","unstructured":"Li, R. et al. Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: A multicenter, retrospective real-world study. BMC Cancer 24(1), 107. https:\/\/doi.org\/10.1186\/s12885-024-11860-3 (2024).","journal-title":"BMC Cancer"},{"key":"51900_CR21","doi-asserted-by":"crossref","unstructured":"Taher, M., Susanti, D., Haris, M. S., Rushdan, A. A., Widodo, R. T., Syukri, Y., & Khotib, J. (2023). PEGylated liposomes enhance the effect of cytotoxic drug: A review. Heliyon, 9(3).","DOI":"10.1016\/j.heliyon.2023.e13823"},{"issue":"1","key":"51900_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0169-5002(01)00269-0","volume":"35","author":"G Numico","year":"2002","unstructured":"Numico, G. et al. Single-agent pegylated liposomal doxorubicin (Caelix\u00ae) in chemotherapy pretreated non-small cell lung cancer patients: A pilot trial. Lung Cancer 35(1), 59\u201364 (2002).","journal-title":"Lung Cancer"},{"key":"51900_CR23","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S153107","author":"L Lu","year":"2018","unstructured":"Lu, L. et al. Antibodymodified liposomes for tumor-targeting delivery of timosaponin AIII. Int. J. Nanomedicine https:\/\/doi.org\/10.2147\/IJN.S153107 (2018).","journal-title":"Int. J. Nanomedicine"},{"key":"51900_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125708","volume":"679","author":"S Pisani","year":"2025","unstructured":"Pisani, S. et al. Assessing liposomal nanocarriers for targeted drug delivery through electroporation. Int. J. Pharm. 679, 125708. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125708 (2025).","journal-title":"Int. J. Pharm."},{"key":"51900_CR25","doi-asserted-by":"crossref","unstructured":"Ann Mathew, A., Panonnummal, R., A, A. K., & M, S. (2025). Formulation, characterization, and in vitro evaluation of lactoferrin conjugated liposome loaded with magnesium sulfate for improved CNS penetrability. J. Liposome Res. 35(4), 503\u2013515.","DOI":"10.1080\/08982104.2025.2560888"},{"key":"51900_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104594","volume":"86","author":"A Medina-Moreno","year":"2023","unstructured":"Medina-Moreno, A., El-Hammadi, M. M. & Arias, J. L. pH-dependent, extended release and enhanced in vitro efficiency against colon cancer of Tegafur formulated using chitosan-coated poly (\u03b5-caprolactone) nanoparticles. J. Drug Deliv. Sci. Technol. 86, 104594 (2023).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"51900_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jddst.2018.12.020","volume":"49","author":"P Rajitha","year":"2019","unstructured":"Rajitha, P. et al. Chaulmoogra oil based methotrexate loaded topical nanoemulsion for the treatment of psoriasis. J. Drug Deliv. Sci. Technol. 49, 463\u2013476 (2019).","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"10","key":"51900_CR28","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00210-023-02468-8","volume":"396","author":"G Chandrababu","year":"2023","unstructured":"Chandrababu, G. et al. Kaempferide exhibits an anticancer effect against hepatocellular carcinoma in vitro and in vivo. Naunyn-Schmiedebergs Arch. Pharmacol. 396(10), 2461\u20132467. https:\/\/doi.org\/10.1007\/s00210-023-02468-8 (2023).","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"issue":"3","key":"51900_CR29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.34172\/apb.2020.058","volume":"10","author":"B Nair","year":"2020","unstructured":"Nair, B., Anto, R. J. & Nath, L. R. Kaempferol-mediated sensitization enhances chemotherapeutic efficacy of sorafenib against hepatocellular carcinoma: An in silico and in vitro approach. Adv. Pharm. Bull. 10(3), 472. https:\/\/doi.org\/10.34172\/apb.2020.058 (2020).","journal-title":"Adv. Pharm. Bull."},{"issue":"11","key":"51900_CR30","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1007\/s13346-022-01142-5","volume":"12","author":"L Gopakumar","year":"2022","unstructured":"Gopakumar, L. et al. Enhanced oral bioavailability and antitumor therapeutic efficacy of sorafenib administered in core\u2013shell protein nanoparticle. Drug Deliv. Transl. Res. 12(11), 2824\u20132837. https:\/\/doi.org\/10.1007\/s13346-022-01142-5 (2022).","journal-title":"Drug Deliv. Transl. Res."},{"key":"51900_CR31","doi-asserted-by":"publisher","unstructured":"Mugale, M. N., Shukla, S., Chourasia, M. K., Hanif, K., Nazir, A., Singh, S., & Bhadauria, S. (2021). Regulatory safety pharmacology and toxicity assessments of a standardized stem extract of Cassia occidentalis Linn. in rodents. Regulatory Toxicology and Pharmacology, 123, 104960. https:\/\/doi.org\/10.1016\/j.yrtph.2021.104960","DOI":"10.1016\/j.yrtph.2021.104960"},{"issue":"10","key":"51900_CR32","doi-asserted-by":"publisher","first-page":"109517","DOI":"10.4254\/wjh.v17.i10.109517","volume":"17","author":"AR Devan","year":"2025","unstructured":"Devan, A. R. et al. Ultrasound imaging-guided protocol for monitoring tumor growth in orthotopic rat model of hepatocellular carcinoma. World J. Hepatol. 17(10), 109517. https:\/\/doi.org\/10.4254\/wjh.v17.i10.109517 (2025).","journal-title":"World J. Hepatol."},{"key":"51900_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ifset.2013.03.006","volume":"19","author":"BD Isailovi\u0107","year":"2013","unstructured":"Isailovi\u0107, B. D. et al. Resveratrol loaded liposomes produced by different techniques. Innov. Food Sci. Emerg. Technol. 19, 181\u2013189. https:\/\/doi.org\/10.1016\/j.ifset.2013.03.006 (2013).","journal-title":"Innov. Food Sci. Emerg. Technol."},{"key":"51900_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cocis.2024.101875","volume":"75","author":"R Eugster","year":"2025","unstructured":"Eugster, R. & Luciani, P. Liposomes: Bridging the gap from lab to pharmaceuticals. Curr. Opin. Colloid Interface Sci. 75, 101875. https:\/\/doi.org\/10.1016\/j.cocis.2024.101875 (2025).","journal-title":"Curr. Opin. Colloid Interface Sci."},{"issue":"2","key":"51900_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei, M. et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10(2), 57. https:\/\/doi.org\/10.3390\/pharmaceutics10020057 (2018).","journal-title":"Pharmaceutics"},{"key":"51900_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/727241","volume":"2011","author":"C Kelly","year":"2010","unstructured":"Kelly, C., Jefferies, C. & Cryan, A. Targeted liposomal drug delivery to monocytes and macrophages. J. Drug Deliv. 2011, 727241. https:\/\/doi.org\/10.1155\/2011\/727241 (2010).","journal-title":"J. Drug Deliv."},{"issue":"1","key":"51900_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-43689-4","volume":"13","author":"B Hoseini","year":"2023","unstructured":"Hoseini, B. et al. Application of ensemble machine learning approach to assess the factors affecting size and polydispersity index of liposomal nanoparticles. Sci. Rep. 13(1), 1\u201311. https:\/\/doi.org\/10.1038\/s41598-023-43689-4 (2023).","journal-title":"Sci. Rep."},{"issue":"9","key":"51900_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091798","volume":"14","author":"Z N\u00e9meth","year":"2022","unstructured":"N\u00e9meth, Z. et al. Quality by design-driven zeta potential optimisation study of liposomes with charge imparting membrane additives. Pharmaceutics 14(9), 1798. https:\/\/doi.org\/10.3390\/pharmaceutics14091798 (2022).","journal-title":"Pharmaceutics"},{"key":"51900_CR39","doi-asserted-by":"publisher","unstructured":"Baxa, U. (2018). Imaging of liposomes by transmission electron microscopy. In S. McNeil (Ed.), Characterization of nanoparticles intended for drug delivery (Vol. 1682, pp. 73\u201388). Humana Press. https:\/\/doi.org\/10.1007\/978-1-4939-7352-1_8","DOI":"10.1007\/978-1-4939-7352-1_8"},{"key":"51900_CR40","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/IJN.S14615","volume":"6","author":"B Ruozi","year":"2011","unstructured":"Ruozi, B. et al. AFM, ESEM, TEM, and CLSM in liposomal characterization: A comparative study. Int. J. Nanomedicine. 6, 557\u2013563. https:\/\/doi.org\/10.2147\/IJN.S14615 (2011).","journal-title":"Int. J. Nanomedicine."},{"key":"51900_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"A Akbarzadeh","year":"2013","unstructured":"Akbarzadeh, A. et al. Liposome: Classification, preparation, and applications. Nanoscale Res. Lett. 8, 1\u20139. https:\/\/doi.org\/10.1186\/1556-276X-8-102 (2013).","journal-title":"Nanoscale Res. Lett."},{"key":"51900_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00080","volume":"9","author":"A Robson","year":"2018","unstructured":"Robson, A. et al. Advantages and limitations of current imaging techniques for characterizing liposome morphology. Front. Pharmacol. 9, 328115. https:\/\/doi.org\/10.3389\/fphar.2018.00080 (2018).","journal-title":"Front. Pharmacol."},{"issue":"2","key":"51900_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/fluids3020036","volume":"3","author":"SK Tsermentseli","year":"2018","unstructured":"Tsermentseli, S. K., Kontogiannopoulos, K. N., Papageorgiou, V. P. & Assimopoulou, A. N. Comparative study of PEGylated and conventional liposomes as carriers for shikonin. Fluids 3(2), 36. https:\/\/doi.org\/10.3390\/fluids3020036 (2018).","journal-title":"Fluids"},{"issue":"3","key":"51900_CR44","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/nano.2006.1.3.297","volume":"1","author":"LM Immordino","year":"2006","unstructured":"Immordino, L. M., Dosio, F. & Cattel, L. Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomedicine 1(3), 297\u2013315. https:\/\/doi.org\/10.2147\/nano.2006.1.3.297 (2006).","journal-title":"Int. J. Nanomedicine"},{"key":"51900_CR45","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S210320","volume":"15","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Lu, Y., Lee, R. J. & Xiang, G. Nano encapsulated curcumin: And its potential for biomedical applications. Int. J. Nanomedicine 15, 3099. https:\/\/doi.org\/10.2147\/IJN.S210320 (2020).","journal-title":"Int. J. Nanomedicine"},{"key":"51900_CR46","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.2147\/IJN.S31439","volume":"7","author":"X Gao","year":"2012","unstructured":"Gao, X. et al. A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation. Int. J. Nanomedicine. 7, 2601. https:\/\/doi.org\/10.2147\/IJN.S31439 (2012).","journal-title":"Int. J. Nanomedicine."},{"issue":"9","key":"51900_CR47","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/pharmaceutics11090465","volume":"11","author":"G Pauli","year":"2019","unstructured":"Pauli, G., Tang, W. & Li, S. Development and characterization of the solvent-assisted active loading technology (SALT) for liposomal loading of poorly water-soluble compounds. Pharmaceutics 11(9), 465. https:\/\/doi.org\/10.3390\/pharmaceutics11090465 (2019).","journal-title":"Pharmaceutics"},{"issue":"2","key":"51900_CR48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.colsurfb.2007.09.003","volume":"61","author":"S Mourtas","year":"2008","unstructured":"Mourtas, S., Duraj, S., Fotopoulou, S. & Antimisiaris, S. G. Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels. Colloids Surf. B Biointerfaces 61(2), 270\u2013276. https:\/\/doi.org\/10.1016\/j.colsurfb.2007.09.003 (2008).","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"51900_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/ph19010135","volume":"19","author":"L Wu","year":"2026","unstructured":"Wu, L., Guo, X. & Guo, P. Study on dual-targeted liposomes containing curcumin-copper chelate in the treatment of triple-negative breast cancer. Pharmaceuticals 19(1), 135 (2026).","journal-title":"Pharmaceuticals"},{"key":"51900_CR50","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2147\/IJN.S228715","volume":"15","author":"B Han","year":"2020","unstructured":"Han, B. et al. Preparation, characterization, and pharmacokinetic study of a novel long-acting targeted paclitaxel liposome with antitumor activity. Int. J. Nanomed. 15, 553\u2013571. https:\/\/doi.org\/10.2147\/IJN.S228715 (2020).","journal-title":"Int. J. Nanomed."},{"key":"51900_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejps.2017.03.003","volume":"103","author":"HM Kieler-Ferguson","year":"2017","unstructured":"Kieler-Ferguson, H. M. et al. Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids. Eur. J. Pharm. Sci. 103, 85\u201393. https:\/\/doi.org\/10.1016\/j.ejps.2017.03.003 (2017).","journal-title":"Eur. J. Pharm. Sci."},{"key":"51900_CR52","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S66312","author":"Y Wei","year":"2014","unstructured":"Wei, Y. et al. Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes. Int. J. Nanomed. https:\/\/doi.org\/10.2147\/IJN.S66312 (2014).","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"51900_CR53","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1002\/fsn3.3499","volume":"11","author":"M Akiyama","year":"2023","unstructured":"Akiyama, M., Mizokami, T., Ito, H. & Ikeda, Y. A randomized, placebo-controlled trial evaluating the safety of excessive administration of kaempferol aglycone. Food Sci. Nutr. 11(9), 5427\u20135437. https:\/\/doi.org\/10.1002\/fsn3.3499 (2023).","journal-title":"Food Sci. Nutr."},{"issue":"10","key":"51900_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102288","volume":"11","author":"WM Dabeek","year":"2019","unstructured":"Dabeek, W. M. & Marra, M. V. Dietary quercetin and kaempferol: Bioavailability and potential cardiovascular-related bioactivity in humans. Nutrients 11(10), 2288. https:\/\/doi.org\/10.3390\/nu11102288 (2019).","journal-title":"Nutrients"},{"issue":"3","key":"51900_CR55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.14429\/dlsj.7.17322","volume":"7","author":"A Sarkar","year":"2022","unstructured":"Sarkar, A. & Roy, B. Biochemical and ultrastructural studies for toxicity of kaempferol derivative recovered from the plant Lysimachia ramosa. Defence Life Sci. J. 7(3), 147\u2013155. https:\/\/doi.org\/10.14429\/dlsj.7.17322 (2022).","journal-title":"Defence Life Sci. J."},{"issue":"6","key":"51900_CR56","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2174\/1389201017666160127110609","volume":"17","author":"S Qian","year":"2016","unstructured":"Qian, S. & Y., Ramamurthy, S., Candasamy, M., Md, S., H Kumar, R., & S Meka, V.,. Production, characterization and evaluation of kaempferol nanosuspension for improving oral bioavailability. Curr. Pharmac. Biotechnol. 17(6), 549\u2013555 (2016).","journal-title":"Curr. Pharmac. Biotechnol."},{"issue":"2","key":"51900_CR57","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3892\/or.2014.3662","volume":"33","author":"H Song","year":"2015","unstructured":"Song, H. et al. Kaempferol inhibits gastric cancer tumor growth: An in vitro and in vivo study. Oncol. Rep. 33(2), 868\u2013874. https:\/\/doi.org\/10.3892\/or.2014.3662 (2015).","journal-title":"Oncol. Rep."},{"key":"51900_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113762","author":"Y Zheng","year":"2025","unstructured":"Zheng, Y. et al. Slow intravenous infusion reduces the accelerated blood clearance of PEGylated liposomes by removing anti-PEG antibodies. J. Control. Release. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113762 (2025).","journal-title":"J. Control. Release."},{"key":"51900_CR59","volume-title":"Volume of Distribution","author":"A Mansoor","year":"2023","unstructured":"Mansoor, A. & Mahabadi, N. Volume of Distribution (StatPearls Publishing, StatPearls, 2023)."},{"issue":"1","key":"51900_CR60","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1038\/s41467-024-50568-7","volume":"15","author":"K Jiang","year":"2024","unstructured":"Jiang, K. et al. Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin. Nat. Commun. 15(1), 6136. https:\/\/doi.org\/10.1038\/s41467-024-50568-7 (2024).","journal-title":"Nat. Commun."},{"key":"51900_CR61","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jconrel.2014.07.010","volume":"192","author":"J Yahuafai","year":"2014","unstructured":"Yahuafai, J. et al. Suppression in mice of immunosurveillance against PEGylated liposomes by encapsulated doxorubicin. J. Control. Release. 192, 167\u2013173. https:\/\/doi.org\/10.1016\/j.jconrel.2014.07.010 (2014).","journal-title":"J. Control. Release."},{"issue":"1","key":"51900_CR62","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40487-022-00215-2","volume":"11","author":"S Barbier","year":"2023","unstructured":"Barbier, S. et al. Liposomal irinotecan shows a larger therapeutic index than non-liposomal irinotecan in patient-derived xenograft models of pancreatic cancer. Oncol. Ther. 11(1), 111\u2013128. https:\/\/doi.org\/10.1007\/s40487-022-00215-2 (2023).","journal-title":"Oncol. Ther."},{"issue":"3","key":"51900_CR63","doi-asserted-by":"publisher","first-page":"S1653","DOI":"10.1016\/S2221-1691(12)60471-7","volume":"2","author":"K Langeswaran","year":"2012","unstructured":"Langeswaran, K., Revathy, R., Kumar, S. G., Vijayaprakash, S. & Balasubramanian, M. P. Kaempferol ameliorates aflatoxin B1 (AFB1) induced hepatocellular carcinoma through modifying metabolizing enzymes, membrane bound ATPases and mitochondrial TCA cycle enzymes. Asian Pac. J. Trop. Biomed. 2(3), S1653\u2013S1659. https:\/\/doi.org\/10.1016\/S2221-1691(12)60471-7 (2012).","journal-title":"Asian Pac. J. Trop. Biomed."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51900-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51900-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51900-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:49:52Z","timestamp":1783464592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51900-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51900"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51900-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21048"}}